Sponsor Pipeline

Queling Liu Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 2/3
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT06977061 Efficacy and Safety of Fruquintinib Combined With Sintilimab and Stereotactic Body… Gastric Neoplasm Not Yet Recruiting
Disease Areas
Get alerts when Queling Liu's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free